New Version of the ICH Q3D Guideline for Impurities published

Recommendation
Wednesday, 21 May 2025 10.00 - 16.00 h
How to use and prepare an MA with a CEP 2.0
Since the end of April 2022, the second revision of the "Guideline for Elemental Impurities Q3D(R2)" of the ICH (INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE) is available on the ICH website under the heading "Quality Guidelines". This version includes revisions and adaptations in Appendices 2 and 3. Appendix 5 has been added.
Appendix 2: Established PDEs for Elemental Impurities
The PDEs (Permitted Daily Exposure) values for the following three substances nickel, gold and silver have been adjusted in Appendix 2.Appendix 3: Individual Safety Assessments
In the third appendix, the passages on the monographs of the substances gold (pages 41-42 of the guideline) and silver (pages 62-63 of the guideline) were revised.Appendix 5: Limits for Elemental Impurities by the Cutaneous and Transcutaneous Route
Appendix 5 was added in the second revision of the guideline and contains information on the limits for impurities for cutaneously or transcutaneously applied medicinal products. This appendix comprises the following eight items, with paragraphs 3 and 4 each containing sub-items:- 1 Background
- 2 Scope
- 3 Principals of Safety Assessment for Cutaneous Products
- 3.1 Transcutaneous Absorption of Elemental Impurities (EI)
- 3.2 PDE for Drug Products Directly Applied to the Dermis - 4 Establishing the Cutaneous Permitted Daily Exposure (PDE)
- 4.1 Establishing the Cutaneous Modifying Factor (CMF)
- 4.2 Cutaneous PDE
- 4.2.1 Derivation of PDE for EI, other than Arsenic (As) and Thallium (Tl)
- 4.2.2 Derivation of PDE for arsenic
- 4.2.3 Derivation of PDE for thallium - 5 Cutaneous Concentration Limits for Ni and Co
- 6 Product Risk Assessment
- 7 Cutaneous PDE Value
- 8 References
The complete "Guideline for Elemental Impurities Q3D(R2)" as well as all other valid "Quality (Q)-Guidelines" can be found on the ICH website.
Related GMP News
16.04.2025EDQM: Excipient Monographs and Reference Standards
09.04.2025FDA Warning Letter: Missing Ongoing Stability Program for Biotech APIs
02.04.2025WHO: Update of Guideline of Reference Standards
26.03.2025EMA: Update of "PLM Portal eAF - Release Notes"
26.03.2025PFAS Restriction in the EU: Pharma Deutschland and VDDI request Comprehensive Exemptions